Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis
© Copyright 2017 The Author(s). Published by Wolters Kluwer Health, Inc. Background: Oral tenofovir disoproxil fumarate (TDF) for HIV prevention and treatment is associated with decreases in bone mineral density (BMD). Previous reports suggest that these changes may be reversible after discontinuati...
Saved in:
Main Authors: | David V. Glidden, Kathleen Mulligan, Vanessa McMahan, Peter L. Anderson, Juan Guanira, Suwat Chariyalertsak, Susan P. Buchbinder, Linda Gail Bekker, Mauro Schechter, Beatriz Grinsztejn, Robert M. Grant |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021110292&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/57608 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis
by: David V. Glidden, et al.
Published: (2018) -
Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
by: David V. Glidden, et al.
Published: (2018) -
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Peter L. Anderson, et al.
Published: (2018) -
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Anderson P., et al.
Published: (2017) -
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
by: Marc M. Solomon, et al.
Published: (2018)